Effectiveness Evaluation of a Dengue Self-monitoring System
NCT05688748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2023-12-08
Summary
The goal of this clinical trial is to compare the effectiveness of a dengue self-monitoring system with standard care in reducing treatment delay among dengue patients receiving outpatient care. The main question it aims to answer are:
• Is a dengue self-monitoring system effective in reducing treatment delay in dengue patients? Participants will use the dengue monitoring system in addition to the standard care they are receiving for outpatient follow up for dengue.
Researchers will compare them with dengue patients receiving the usual standard care to see if the dengue monitoring system reduces delay in treatment seeking in patients.
Conditions
- Dengue
Interventions
- OTHER
-
Dengue self-monitoring system
The system has a symptom monitoring algorithm whereby patient would be asked to report their symptoms thrice daily (9am, 2pm and 8pm). The algorithm is developed by the researchers which consist of primary care doctors, emergency physician and infectious disease specialists. If the patient reports warning symptoms (persistent vomiting, persistent diarrhoea, abdominal pain, bleeding, difficulty breathing, feel like fainting, difficulty carrying out usual activities, drowsiness, reduced urine output and reduced urine output), the system will advise patients to seek earlier medical care instead of waiting for the scheduled appointment the next day/other days.
Sponsors & Collaborators
-
Ministry of Health, Malaysia
collaborator OTHER_GOV -
University of Malaya
lead OTHER
Principal Investigators
-
Wei Leik Ng · University of Malaya
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-20
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- Malaysia
Study Locations
More Related Trials
-
Malaria Active Epidemiology and Treatment Study
NCT01280162 ·Status: COMPLETED ·Phase: NA
-
Innovation Platform
NCT04558528 ·Status: COMPLETED
-
Amodiaquine+Artesunate for Uncomplicated Malaria Treatment
NCT01213433 ·Status: COMPLETED ·Phase: PHASE4
-
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
NCT01228344 ·Status: COMPLETED
-
Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger
NCT01755559 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Trial of Malaria Seasonal IPTc Combined With Community Case Management
NCT01449045 ·Status: COMPLETED ·Phase: PHASE3
-
DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria
NCT02450578 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya
NCT02987270 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia
NCT02510638 ·Status: COMPLETED
-
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
NCT00393679 ·Status: COMPLETED ·Phase: PHASE3
-
ACT MALI: Treatment of Malaria Based on Combination Therapies
NCT00452907 ·Status: COMPLETED ·Phase: PHASE4
-
Harmonized AS/MQ Efficacy Study - Thailand
NCT02052323 ·Status: COMPLETED ·Phase: PHASE4
-
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites
NCT05070520 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
NCT05951595 ·Status: RECRUITING ·Phase: PHASE3
-
Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults
NCT02992119 ·Status: COMPLETED ·Phase: PHASE2
-
Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal
NCT00529620 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra
NCT01389557 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria
NCT01288820 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria
NCT02353494 ·Status: COMPLETED
-
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
NCT03576313 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
NCT00540410 ·Status: COMPLETED ·Phase: PHASE4
-
Ethiopia Malaria Therapeutic Efficacy Study
NCT01052584 ·Status: COMPLETED ·Phase: NA